Muscle Health - Made in USA - Enhance Muscle Mass & Strength, Fast Workout Recovery, Reduce Fatigue & Boost Exercise Performance, 6-Sialyllactose (6-SL), 900mg, 90 Tablets
12 sold in last 24 hours
- 6’-Sialyllactose: 6’-SL, a clinically tested and scientifically supported novel ingredient, plays a unique function on muscle health. 6’-SL inhibits muscle protein degradation while promoting muscle protein synthesis. 6’-SL keeps muscle health by maintaining the balance between muscle protein synthesis and degradation.
- Human Clinical Trial: 6’-SL demonstrated promising potentials for subjects with muscle health challenges in a 96-week clinical trial. (Source DOI: 10.1016/j.biopha.2023.115689)
- Muscle Mass Increase: 6’-SL boosted an essential muscle protein (Myosin Heavy Chain) production and muscle fiber size. 6’-SL helped muscle mass increase in key lower leg muscles, Gastrocnemius and Soleus muscle. (Source DOI: 10.3390/nu16162600)
- Muscle Strength Improvement: 6′-SL administration resulted in increased muscle strength in both normal and dexamethasone-induced muscle weakness conditions. Both cases showed a notable improvement in grip strength. (Source DOI: 10.3390/nu16162600, 10.1016/j.bbrc.2024.150892)
- Muscle Fatigue Reduction: 6′-SL helps reduce muscle fatigue by lowering blood lactate levels, supporting better work performance during endurance exercise. (Source DOI: 10.3390/nu16172957)
- Muscle Protein Degradation Suppression: 6′-SL suppressed muscle protein degradation pathways and recovered not only weakened muscle mass but also muscle strength in a dexamethasone-induced muscle weakness conditions in an animal clinical study. (Source DOI: 10.1016/j.bbrc.2024.150892)
Svarbi informacija
Sudėtis
6'-Sialyllactose (6'-SL)
Nurodymai
Adult
Teisinis atsakomybės apribojimas
Pareiškimai dėl maisto papildų nebuvo įvertinti FDA ir nėra skirti diagnozuoti, gydyti, išgydyti, ar užkirsti kelią bet kokiai ligai ar sveikatos būklei.
Produkto matmenys
3,54 x 1,93 x 1,93 colių; 2,08 uncijos
| Prekės ženklas | Siallakas |
| Galiojimo pabaigos data | 2026 m. lapkritis |
| Sudėtis | 6 '-Sialillaktozė (6' -Sl) |









